Cargando…

Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1

PURPOSE: To determine the prevalence of choroidal abnormalities (CAs) and Lisch nodules (LNs) in children who met the clinical diagnostic criteria (CDC) alone and those with a molecularly confirmed diagnosis (MCD) of neurofibromatosis type 1 (NF1), and to ascertain any differences between the groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores Pimentel, Mariana, Heath, Anna, Wan, Michael J., Hussein, Rowaida, Leahy, Kate E., MacDonald, Heather, Tavares, Erika, VandenHoven, Cynthia, MacNeill, Katelyn, Kannu, Peter, Parkin, Patricia C., Heon, Elise, Reginald, Arun, Vincent, Ajoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819284/
https://www.ncbi.nlm.nih.gov/pubmed/35119474
http://dx.doi.org/10.1167/tvst.11.2.10
_version_ 1784646026613751808
author Flores Pimentel, Mariana
Heath, Anna
Wan, Michael J.
Hussein, Rowaida
Leahy, Kate E.
MacDonald, Heather
Tavares, Erika
VandenHoven, Cynthia
MacNeill, Katelyn
Kannu, Peter
Parkin, Patricia C.
Heon, Elise
Reginald, Arun
Vincent, Ajoy
author_facet Flores Pimentel, Mariana
Heath, Anna
Wan, Michael J.
Hussein, Rowaida
Leahy, Kate E.
MacDonald, Heather
Tavares, Erika
VandenHoven, Cynthia
MacNeill, Katelyn
Kannu, Peter
Parkin, Patricia C.
Heon, Elise
Reginald, Arun
Vincent, Ajoy
author_sort Flores Pimentel, Mariana
collection PubMed
description PURPOSE: To determine the prevalence of choroidal abnormalities (CAs) and Lisch nodules (LNs) in children who met the clinical diagnostic criteria (CDC) alone and those with a molecularly confirmed diagnosis (MCD) of neurofibromatosis type 1 (NF1), and to ascertain any differences between the groups. METHODS: This was a cross-sectional observational study. All children who met the CDC and/or had MCD of NF1 and underwent eye examination were included. At least two CAs or LNs between the two eyes were set as a threshold to define the presence of either abnormality. Frequencies alongside 95% confidence intervals (CIs) were calculated. The relationship between patient age and the presence of LNs and/or CAs was estimated using logistic regression. RESULTS: The study cohort included 94 patients; CAs (64%) were more prevalent than LNs (41%) (0.22; 95% CI, 0.08–0.36; P = 0.0023). The probability of the presence of LNs was lower than that of CAs across all ages (odds ratio = 0.37; 95% CI, 0.20–0.69; P = 0.00173). CAs were exclusively found in 37% of patients and LNs in 16%; 80% had either CAs or LNs, or both. In the CDC group (n = 41), the difference in prevalence (CAs = 68%, LNs = 51%) did not attain statistical significance (0.17; 95% CI, −0.06 to 0.40; P = 0.18). In the MCD group (n = 53), the difference in prevalence (CAs = 60%, LNs = 34%) was significant (0.26; 95% CI, 0.006–0.47; P = 0.023). CONCLUSIONS: CAs were more frequent than LNs in pediatric NF1 patients regardless of age and MCD status. Combining ophthalmological exams with near-infrared imaging will increase the diagnostic reach in pediatric NF1. TRANSLATIONAL RELEVANCE: CAs detected on near-infrared imaging are objective biomarkers in NF1. They are more prevalent and detected earlier in the pediatric population compared with LNs. Hence, the presence of CAs should be routinely ascertained in children suspected with NF1.
format Online
Article
Text
id pubmed-8819284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-88192842022-02-18 Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 Flores Pimentel, Mariana Heath, Anna Wan, Michael J. Hussein, Rowaida Leahy, Kate E. MacDonald, Heather Tavares, Erika VandenHoven, Cynthia MacNeill, Katelyn Kannu, Peter Parkin, Patricia C. Heon, Elise Reginald, Arun Vincent, Ajoy Transl Vis Sci Technol Article PURPOSE: To determine the prevalence of choroidal abnormalities (CAs) and Lisch nodules (LNs) in children who met the clinical diagnostic criteria (CDC) alone and those with a molecularly confirmed diagnosis (MCD) of neurofibromatosis type 1 (NF1), and to ascertain any differences between the groups. METHODS: This was a cross-sectional observational study. All children who met the CDC and/or had MCD of NF1 and underwent eye examination were included. At least two CAs or LNs between the two eyes were set as a threshold to define the presence of either abnormality. Frequencies alongside 95% confidence intervals (CIs) were calculated. The relationship between patient age and the presence of LNs and/or CAs was estimated using logistic regression. RESULTS: The study cohort included 94 patients; CAs (64%) were more prevalent than LNs (41%) (0.22; 95% CI, 0.08–0.36; P = 0.0023). The probability of the presence of LNs was lower than that of CAs across all ages (odds ratio = 0.37; 95% CI, 0.20–0.69; P = 0.00173). CAs were exclusively found in 37% of patients and LNs in 16%; 80% had either CAs or LNs, or both. In the CDC group (n = 41), the difference in prevalence (CAs = 68%, LNs = 51%) did not attain statistical significance (0.17; 95% CI, −0.06 to 0.40; P = 0.18). In the MCD group (n = 53), the difference in prevalence (CAs = 60%, LNs = 34%) was significant (0.26; 95% CI, 0.006–0.47; P = 0.023). CONCLUSIONS: CAs were more frequent than LNs in pediatric NF1 patients regardless of age and MCD status. Combining ophthalmological exams with near-infrared imaging will increase the diagnostic reach in pediatric NF1. TRANSLATIONAL RELEVANCE: CAs detected on near-infrared imaging are objective biomarkers in NF1. They are more prevalent and detected earlier in the pediatric population compared with LNs. Hence, the presence of CAs should be routinely ascertained in children suspected with NF1. The Association for Research in Vision and Ophthalmology 2022-02-04 /pmc/articles/PMC8819284/ /pubmed/35119474 http://dx.doi.org/10.1167/tvst.11.2.10 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Article
Flores Pimentel, Mariana
Heath, Anna
Wan, Michael J.
Hussein, Rowaida
Leahy, Kate E.
MacDonald, Heather
Tavares, Erika
VandenHoven, Cynthia
MacNeill, Katelyn
Kannu, Peter
Parkin, Patricia C.
Heon, Elise
Reginald, Arun
Vincent, Ajoy
Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
title Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
title_full Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
title_fullStr Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
title_full_unstemmed Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
title_short Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
title_sort prevalence of choroidal abnormalities and lisch nodules in children meeting clinical and molecular diagnosis of neurofibromatosis type 1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819284/
https://www.ncbi.nlm.nih.gov/pubmed/35119474
http://dx.doi.org/10.1167/tvst.11.2.10
work_keys_str_mv AT florespimentelmariana prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT heathanna prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT wanmichaelj prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT husseinrowaida prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT leahykatee prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT macdonaldheather prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT tavareserika prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT vandenhovencynthia prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT macneillkatelyn prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT kannupeter prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT parkinpatriciac prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT heonelise prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT reginaldarun prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1
AT vincentajoy prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1